Package Leaflet: Information for the User
Lercanidipine Pensa 10 mg Film-Coated Tablets EFG
Lercanidipine Pensa 20 mg Film-Coated Tablets EFG
lercanidipine hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Lercanidipine belongs to a group of medicines called calcium channel blockers (of the dihydropyridine type) that lower blood pressure.
Lercanidipine is used to treat high blood pressure, also known as arterial hypertension in adults over 18 years old (it is not recommended for children under 18 years old).
Consult your doctor or pharmacist before starting to take this medicine:
You should inform your doctor if you think you are pregnant (may become pregnant) or are breastfeeding (see section on pregnancy, breastfeeding, and fertility).
The safety and efficacy of lercanidipine have not been demonstrated in children under 18 years old.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This is because when lercanidipine is combined with other medicines, the effect of lercanidipine or the other medicine may change or the frequency of certain side effects may increase (see also section 2 “Do not take Lercanidipine Pensa”).
In particular, inform your doctor or pharmacist if you are taking any of the following medicines:
It is not recommended to take lercanidipine if you are pregnant and it should not be taken during breastfeeding. There are no data on the use of lercanidipine in pregnant or breastfeeding women. If you are pregnant or breastfeeding, if you are not using an effective contraceptive method, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
If you suffer from dizziness, weakness, or numbness when taking this medicine, do not drive vehicles or use machines.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Adults
The usual recommended dose is one 10 mg tablet daily at the same time each day, preferably in the morning and at least 15 minutes before breakfast. Your doctor may increase your dose to lercanidipine 20 mg daily, if necessary (see section 2 “Taking Lercanidipine Pensa with food, drinks, and alcohol”).
The tablets should be swallowed preferably whole with a little water.
The score line is only to facilitate breaking the tablet if you have difficulty swallowing it whole.
Use in children
This medicine should not be used in children under 18 years old.
Elderly population
No dose adjustment is required. However, they may require special care at the start of treatment.
Patients with kidney or liver problems
Special care is needed when starting treatment in these patients and an increase in dose to 20 mg daily should be done with caution.
Do not take more than the prescribed dose.
If you have taken more tablets of this medicine than you should, consult your doctor or go directly to the hospital. Take the pack with you.
Taking a higher dose than the correct dose may cause a significant drop in blood pressure and irregular and faster heartbeats.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take your tablet, do not take the forgotten dose, and then continue the next day as your doctor indicated.
Do not take a double dose to make up for forgotten doses.
If you stop taking this medicine, your blood pressure will increase again. Consult your doctor before stopping treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may occur when taking this medicine:
Rare (may affect up to 1 in 1,000 patients):angina pectoris (e.g., chest pressure due to lack of blood in your heart), allergic reactions (with symptoms such as itching, rash, and hives), and fainting.
Patients with pre-existing angina pectoris may experience an increase in frequency, duration, or severity of these attacks with medicines of the group to which lercanidipine belongs. Isolated cases of heart attacks have been observed.
Common (may affect up to 1 in 10 patients):headache, rapid heartbeat, sensation of rapid or accelerated heartbeats (palpitations), sudden reddening of the face, neck, or upper chest (flushing), swelling of the ankles.
Uncommon (may affect up to 1 in 100 patients):dizziness, low blood pressure, heartburn, discomfort, stomach pain, skin rash, itching, muscle pain, increased urination, weakness or fatigue.
Rare (may affect up to 1 in 1,000 patients):drowsiness, vomiting, diarrhea, hives, increased urination frequency, chest pain.
Frequency not known (cannot be estimated from the available data):gum swelling, changes in liver function (detected in blood tests), cloudy fluid (when performing hemodialysis through a tube into the abdomen), swelling of the face, lips, tongue, or throat that may cause difficulty breathing or swallowing.
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report side effects directly through the national reporting system: Spanish Medicines and Healthcare Products Agency (AEMPS) http://www.aemps.gob.es/. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date, which is stated on the blister and carton after “EXP”. The expiry date is the last day of the month stated.
Lercanidipine Pensa 10 mg film-coated tablets EFG:
Store in the original package to protect from light. Do not store above 25°C.
Lercanidipine Pensa 20 mg film-coated tablets EFG:
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Lercanidipine Pensa 10 mg film-coated tablets EFG:
Lercanidipine Pensa 20 mg film-coated tablets EFG:
Lercanidipine Pensa 10 mg film-coated tablets EFG
Yellow, biconvex, film-coated tablets with a score line on one side and a diameter of approximately 6.5 mm.
Lercanidipine Pensa 20 mg film-coated tablets EFG
Pink, biconvex, film-coated tablets with a score line on one side and a diameter of approximately 8.5 mm.
Lercanidipine Pensa 10 mg is available in packs of 14, 28, and 56 film-coated tablets.
Lercanidipine Pensa 20 mg is available in packs of 28 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer
Torrent Pharma (Malta) Limited
HHF 028 Hal Far Industrial Estate
Birzebbuga BBG 3000
Malta
Spain: Lercanidipine Pensa 10 mg film-coated tablets EFG
Lercanidipine Pensa 20 mg film-coated tablets EFG
Italy: Lercanidipina cloridrato Pensa
Portugal: Lercanidipina toLife
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/